Vasantha Jotwani, MD

Associate Professor

I am a clinician-investigator at UCSF and the San Francisco VA Medical Center, and my goal is to reduce the burden of kidney disease by identifying and intervening on kidney injury at the earliest stages. I am the recipient of a NHLBI-funded R01 to investigate the intersection of mitochondrial health, cardiovascular risk and blood pressure targets in hypertensive adults, and a NIDDK-funded K23 award focused on urinary biomarkers for detection of drug-induced nephrotoxicity in persons with and without HIV infection. My initial work demonstrated the potential for urinary biomarkers to capture distinct types of kidney damage and to prognosticate long-term kidney risk in HIV-infected individuals. With our collaborators, we built a panel of urinary biomarkers to detect kidney damage across the nephron; these markers have been studied in various settings as indicators of acute kidney injury and chronic kidney disease. My work made the novel contribution that biomarkers specific for tubular dysfunction and injury can be used to identify tubular toxicity from antiretroviral medications, both in HIV-infected individuals and in HIV-uninfected individuals receiving pre-exposure prophylaxis. Additionally, I am a co-Investigator for an ongoing NIDDK-funded R01 that focuses on urinary biomarkers of kidney tubular health in SPRINT participants with CKD. I also serve as a co-Investigator for a NIA-funded R01 that aims to investigate the role of mitochondrial health in acute and chronic kidney diseases and a NIDDK-funded R01 that will examine the impact of mitochondrial health on kidney function in an exercise trial.

I am dedicated to my clinical practice as a nephrologist, and I care for patients at the San Francisco VA Medical Center (SFVAMC) and UCSF Parnassus Medical Center. At the SFVAMC, I serve on the inpatient nephrology consult service and I provide outpatient nephrology consultation services for referring physicians through the SFVA Renal clinic. I also provide outpatient nephrology consultation services through the UCSF Parnassus Nephrology practice, where I have held an ambulatory panel since 2014. I manage a small dialysis practice at Satellite Health and Wellbound for my patients who have progressed to end-stage kidney disease.

Finally, I serve as the SFVAMC Site Director for the UCSF Nephrology Fellowship program. In this capacity, I oversee the nephrology fellows on all clinical, elective and research rotations at the SFVAMC. I am responsible for design, organization, and implementation of the weekly fellowship lecture series, and I chair the Nephrology Fellowship Program Evaluation Committee. In July of 2021, we launched a wellness program for the UCSF Nephrology Fellowship program. Developed with input from fellows and with the support of division leadership, our multi-pronged program includes social events to improve fellows' sense of connection, monthly tips that address health and well-being, and monthly recognition of 2-3 fellows to appreciate their efforts.

Education
Clinical Fellowship, 2014 - Division of Nephrology, University of California San Francisco
Chief Residency, 2012 - Internal Medicine, University of California San Francisco
Residency, 2011 - Internal Medicine, University of California San Francisco
Internship, 2009 - Internal Medicine, University of California San Francisco
M.D., 2008 - Feinberg School of Medicine, Northwestern University
BS, 2003 - Biomedical Engineering, Northwestern University
Websites
Publications
  1. Odden MC, Li Y, Jotwani V, Dobrota S, Tan A, Cummings SR, Shlipak MG, Scherzer R, Ix JH, Buckwalter M, Tranah GJ. Joint and Individual Mitochondrial DNA Variation and Cognitive Outcomes in Black and White Older Adults. The journals of gerontology. Series A, Biological sciences and medical sciences 2024. PMID: 39007867


  2. Jotwani V, Thiessen-Philbrook H, Arking DE, Yang SY, McArthur E, Garg AX, Katz R, Tranah GJ, Ix JH, Cummings S, Waikar SS, Sarnak MJ, Shlipak MG, Parikh SM, Parikh CR. Association of Blood Mitochondrial DNA Copy Number With Risk of Acute Kidney Injury After Cardiac Surgery. American journal of kidney diseases : the official journal of the National Kidney Foundation 2024. PMID: 38640995


  3. Jotwani V, Yang SY, Thiessen-Philbrook H, Parikh CR, Katz R, Tranah GJ, Ix JH, Cummings S, Waikar SS, Shlipak MG, Sarnak MJ, Parikh SM, Arking DE. Mitochondrial genetic variation and risk of chronic kidney disease and acute kidney injury in UK Biobank participants. Human genetics 2024. PMID: 38349571


  4. Michelle Odden, Yongmei Li, Vasantha Jotwani, Lea McGeever, Robyn Jones, Pierre-Yves Desprez, Gregory J. Tranah. Mitochondrial DNA variants and Cognitive Function. Alzheimer's & Dementia 2023. PMID:


  5. Ascher SB, Berry JD, Katz R, de Lemos JA, Bansal N, Garimella PS, Hallan SI, Wettersten N, Jotwani VK, Killeen AA, Ix JH, Shlipak MG. Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in the SPRINT Trial. American journal of kidney diseases : the official journal of the National Kidney Foundation 2023. PMID: 37992982


  6. Sheshadri A, Lai M, Hsu FC, Bauer SR, Chen SH, Tse W, Jotwani V, Tranah GJ, Lai JC, Hallan S, Fielding RA, Liu C, Ix JH, Coca SG, Shlipak MG. Structured Moderate Exercise and Biomarkers of Kidney Health in Sedentary Older Adults: The Lifestyle Interventions and Independence for Elders Randomized Clinical Trial. Kidney Medicine 2023. PMID: 37915963


  7. Garimella PS, Scherzer R, Kestenbaum BR, Hoofnagle AN, Jotwani V, Gustafson D, Karim R, Sharma A, Cohen M, Dumond J, Abraham A, Estrella M, Shlipak MG, Ix JH. tubular secretory solute clearance and hiv infection. Journal of acquired immune deficiency syndromes (1999) 2023. PMID: 36988544


  8. Vasantha Jotwani, Heather Thiessen Philbrook, Ronit Katz, Dan Arking, Joachim H. Ix, Gregory J. Tranah, Sushrut S. Waikar, Samir M. Parikh, Mark J. Sarnak, Michael Shlipak, Chirag R. Parikh. Associations of Blood Mitochondrial DNA Copy Number With Risk of AKI After Cardiac Surgery. Complement Activation 2022. PMID:


  9. Anoop Sheshadri, Mason Lai, Fang-Chi Hsu, Scott R. Bauer, Shyh-Huei Chen, Vasantha Jotwani, Gregory J. Tranah, Roger A. Fielding, Christine Liu, Joachim H. Ix, Steven G. Coca, Michael Shlipak. Effect of Structured Exercise on Biomarkers of Kidney Health in Sedentary Older Adults in the LIFE Study: A Randomized Clinical Trial. Complement Activation 2022. PMID:


  10. Joachim H. Ix, Ronit Katz, Judy Shigenaga, Alfred K. Cheung, Kalani L. Raphael, Stein I. Hallan, Jesse C. Seegmiller, Rakesh Malhotra, Vasantha Jotwani, Pranav S. Garimella, Michael Shlipak. In SPRINT Participants With Creatinine Elevations During Follow-Up, Trajectories of Tubule Injury Markers Associate With eGFR Decline. Complement Activation 2022. PMID:


  11. Vasantha Jotwani, Mark J. Sarnak, Heather Thiessen Philbrook, Ronit Katz, Joachim H. Ix, Sushrut S. Waikar, Chirag R. Parikh, Gregory J. Tranah, Samir M. Parikh, Michael Shlipak, Dan Arking. Mitochondrial DNA Haplotypes and Risk of CKD and AKI. Complement Activation 2022. PMID:


  12. Huihui Huang, Zsuzsanna K. Zsengeller, Vasantha Jotwani, Heather Thiessen Philbrook, Ronit Katz, Joachim H. Ix, Chirag R. Parikh, Dan Arking, Mark J. Sarnak, Michael Shlipak, Sushrut S. Waikar, Samir M. Parikh. Quantitative In Situ Assessments of Mitochondrial Impairment Are Associated With Progressive Kidney Disease. Complement Activation 2022. PMID:


  13. Ascher SB, Shlipak MG, Katz R, Bullen AL, Scherzer R, Hallan SI, Cheung AK, Raphael KL, Estrella MM, Jotwani VK, Seegmiller JC, Ix JH, Garimella PS. Estimated Kidney Tubular Secretion and Kidney, Cardiovascular, and Mortality Outcomes in CKD: The Systolic Blood Pressure Intervention Trial. Kidney Medicine 2022. PMID: 36507053


  14. Ascher SB, Scherzer R, Estrella MM, Berry JD, de Lemos JA, Jotwani VK, Garimella PS, Malhotra R, Bullen AL, Katz R, Ambrosius WT, Cheung AK, Chonchol M, Killeen AA, Ix JH, Shlipak MG, SPRINT research group. Kidney tubule health, mineral metabolism, and adverse events in persons with CKD in SPRINT. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2021. PMID: 34473302


  15. Bullen AL, Ascher SB, Scherzer R, Garimella PS, Katz R, Hallan SI, Cheung AK, Raphael KL, Estrella MM, Jotwani VK, Malhotra R, Seegmiller JC, Shlipak MG, Ix JH. Markers of Kidney Tubular Secretion and Risk of Adverse Events in SPRINT Participants with CKD. Journal of the American Society of Nephrology : JASN 2022. PMID: 35973732


  16. Shlipak MG, Sheshadri A, Hsu FC, Chen SH, Jotwani V, Tranah G, Fielding RA, Liu CK, Ix J, Coca SG, LIFE Investigators. Effect of Structured, Moderate Exercise on Kidney Function Decline in Sedentary Older Adults: An Ancillary Analysis of the LIFE Study Randomized Clinical Trial. 2022. PMID: 35499834


  17. Ascher SB, Scherzer R, de Lemos JA, Estrella MM, Jotwani VK, Garimella PS, Bullen AL, Ambrosius WT, Ballantyne CM, Nambi V, Killeen AA, Ix JH, Shlipak MG, Berry JD. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT. 2022. PMID: 35243872


  18. Anthony N. Muiru, Rebecca Scherzer, Simon Ascher, Vasantha Jotwani, Derek Ng, Deborah Gustafson, Amanda B. Spence, Chirag R. Parikh, Anjali Sharma, Joachim H. Ix, Michelle M. Estrella, Michael Shlipak. Associations of CKD Risk Factors and Longitudinal Changes in Urine Biomarkers of Kidney Tubules Among Women Living with HIV. Complement Activation 2021. PMID:


  19. Michael Shlipak, Fang-Chi Hsu, Vasantha Jotwani, Gregory J. Tranah, Roger A. Fielding, Christine Liu, Joachim H. Ix, Steven G. Coca. Can Structured, Moderate Exercise Slow Kidney Function Decline in Sedentary Elders?. Complement Activation 2021. PMID:


  20. Simon Ascher, Rebecca Scherzer, Pranav S. Garimella, Ronit Katz, Stein I. Hallan, Vasantha Jotwani, Rakesh Malhotra, Michelle M. Estrella, Jesse C. Seegmiller, Joachim H. Ix, Michael Shlipak, Alexander Bullen. Markers of Kidney Tubular Secretion and Risk of Adverse Events in Persons with CKD in SPRINT. Complement Activation 2021. PMID:


  21. Simon Ascher, Ronit Katz, Rebecca Scherzer, Alexander Bullen, Stein I. Hallan, Vasantha Jotwani, Rakesh Malhotra, Michelle M. Estrella, Jesse C. Seegmiller, Joachim H. Ix, Michael Shlipak, Pranav S. Garimella. Markers of Kidney Tubular Secretion and Risk of Cardiovascular Disease and Mortality in Persons with CKD in SPRINT. Complement Activation 2021. PMID:


  22. Pranav S. Garimella, Simon Ascher, Ronit Katz, Alexander Bullen, Michelle M. Estrella, Rakesh Malhotra, Vasantha Jotwani, Stein I. Hallan, Rebecca Scherzer, Michael Shlipak, Joachim H. Ix. Tubular Secretion Markers and Declining Kidney Function in the SPRINT Trial. Complement Activation 2021. PMID:


  23. Muiru AN, Scherzer R, Ascher SB, Jotwani V, Grunfeld C, Shigenaga J, Spaulding KA, Ng DK, Gustafson D, Spence AB, Sharma A, Cohen MH, Parikh CR, Ix JH, Estrella MM, Shlipak MG. Associations of CKD risk factors and longitudinal changes in urine biomarkers of kidney tubules among women living with HIV. BMC nephrology 2021. PMID: 34461840


  24. Bullen AL, Katz R, Jotwani V, Garimella PS, Lee AK, Estrella MM, Shlipak MG, Ix JH. Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants. American journal of kidney diseases : the official journal of the National Kidney Foundation 2021. PMID: 33857535


  25. Ascher SB, Scherzer R, Estrella MM, Jotwani VK, Shigenaga J, Spaulding KA, Ng DK, Gustafson D, Spence AB, Sharma A, Cohen MH, Parikh CR, Ix JH, Shlipak MG. Urine Biomarkers of Kidney Tubule Health and Incident CKD Stage 3 in Women Living With HIV: A Repeated Measures Study. Kidney Medicine 2021. PMID: 34136786


  26. Ascher SB, Scherzer R, Estrella MM, Muiru AN, Jotwani VK, Grunfeld C, Shigenaga J, Spaulding KA, Ng DK, Gustafson D, Spence AB, Sharma A, Cohen MH, Parikh CR, Ix JH, Shlipak MG. Kidney tubule health scores and their associations with incident CKD in women living with HIV. HIV medicine 2021. PMID: 33751761


  27. Malhotra R, Katz R, Jotwani V, Agarwal A, Cohen DL, Cushman WC, Ishani A, Killeen AA, Kitzman DW, Oparil S, Papademetriou V, Parikh CR, Raphael KL, Rocco MV, Tamariz LJ, Whelton PK, Wright JT, Shlipak MG, Ix JH. Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial). American journal of kidney diseases : the official journal of the National Kidney Foundation 2020. PMID: 33333147


  28. Jotwani V, Garimella PS, Katz R, Malhotra R, Bates J, Cheung AK, Chonchol M, Drawz PE, Freedman BI, Haley WE, Killeen AA, Punzi H, Sarnak MJ, Segal MS, Shlipak MG, Ix JH. Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants. American journal of nephrology 2020. PMID: 32906135


  29. Ascher SB, Scherzer R, Estrella MM, Shigenaga J, Spaulding KA, Glidden DV, Mehrotra ML, Defechereux P, Gandhi M, Grant RM, Shlipak MG, Jotwani V. HIV pre-exposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health. AIDS (London, England) 2019. PMID: 31794523


  30. Malhotra R, Katz R, Jotwani V, Ambrosius WT, Raphael KL, Haley W, Rastogi A, Cheung AK, Freedman BI, Punzi H, Rocco MV, Ix JH, Shlipak MG. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD. Clinical journal of the American Society of Nephrology : CJASN 2020. PMID: 32111704


  31. Garimella PS, Lee AK, Ambrosius WT, Bhatt U, Cheung AK, Chonchol M, Craven T, Hawfield AT, Jotwani V, Killeen A, Punzi H, Sarnak MJ, Wall BM, Ix JH, Shlipak MG. Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial. European heart journal 2019. PMID: 31257404


  32. Ascher SB, Scherzer R, Nishtala A, Jotwani V, Grunfeld C, Parikh CR, Ng D, Wang R, Palella FJ, Shlipak MG, Estrella MM. Association of Statin Use with Kidney Damage and Function Among HIV-infected Men. Journal of acquired immune deficiency syndromes (1999) 2019. PMID: 31356467


  33. Ascher SB, Scherzer R, Estrella MM, Shlipak MG, Ng DK, Palella FJ, Witt MD, Ho K, Bennett MR, Parikh CR, Ix JH, Jotwani V. Associations of Urine Biomarkers with Kidney Function Decline in HIV-Infected and Uninfected Men. American journal of nephrology 2019. PMID: 31553981


  34. Lee AK, Katz R, Jotwani V, Garimella PS, Ambrosius WT, Cheung AK, Gren LH, Neyra JA, Punzi H, Raphael KL, Shlipak MG, Ix JH. Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality. Hypertension (Dallas, Tex. : 1979) 2019. PMID: 31378102


  35. Bullen AL, Katz R, Lee AK, Anderson CAM, Cheung AK, Garimella PS, Jotwani V, Haley WE, Ishani A, Lash JP, Neyra JA, Punzi H, Rastogi A, Riessen E, Malhotra R, Parikh CR, Rocco MV, Wall BM, Bhatt UY, Shlipak MG, Ix JH, Estrella MM. The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury. Kidney international 2019. PMID: 31262489


  36. Jotwani VK, Lee AK, Estrella MM, Katz R, Garimella PS, Malhotra R, Rifkin DE, Ambrosius W, Freedman BI, Cheung AK, Raphael KL, Drawz P, Neyra JA, Oparil S, Punzi H, Shlipak MG, Ix JH. Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease. American journal of nephrology 2019. PMID: 30939472


  37. Zhang WR, Scherzer R, Estrella MM, Ascher SB, Muiru A, Jotwani V, Grunfeld C, Parikh CR, Gustafson D, Kassaye S, Sharma A, Cohen M, Tien PC, Ng DK, Palella FJ, Witt MD, Ho K, Shlipak MG. Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women. AIDS (London, England) 2019. PMID: 30830887


  38. Alexandra K Lee, Ronit Katz, Walter T Ambrosius, Alfred K Cheung, Pranav Garimella, Lisa H Gren, Vasantha Jotwani, Javier A Neyra, Henry Punzi, Kalani Raphael, Joachim H Ix, Michael Shlipak. Abstract MP09: Indices of Kidney Tubular Health Improve Cardiovascular Disease Risk Prediction in Adults With Hypertension and Chronic Kidney Disease in SPRINT. Circulation 2019. PMID:


  39. Muiru AN, Shlipak MG, Scherzer R, Zhang WR, Ascher SB, Jotwani V, Grunfeld C, Parikh CR, Ng D, Palella FJ, Ho K, Kassaye S, Sharma A, Cohen M, Wang R, Qi Q, Estrella MM. Kidney disease risk factors associate with urine biomarkers concentrations in HIV-positive persons; a cross-sectional study. BMC nephrology 2019. PMID: 30606136


  40. Ascher SB, Scherzer R, Estrella MM, Zhang WR, Muiru AN, Jotwani V, Grunfeld C, Parikh CR, Gustafson D, Young M, Sharma A, Cohen MH, Ng DK, Palella FJ, Witt MD, Ho K, Shlipak MG. Association of Urinary Biomarkers of Kidney Injury with Estimated GFR Decline in HIV-Infected Individuals following Tenofovir Disoproxil Fumarate Initiation. Clinical journal of the American Society of Nephrology : CJASN 2018. PMID: 30154221


  41. Jotwani V, Scherzer R, Glidden DV, Mehrotra M, Defechereux P, Liu A, Gandhi M, Bennett M, Coca SG, Parikh CR, Grant RM, Shlipak MG. Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals. Journal of acquired immune deficiency syndromes (1999) 2018. PMID: 29767638


  42. Jotwani V, Katz R, Ix JH, Gutiérrez OM, Bennett M, Parikh CR, Cummings SR, Sarnak MJ, Shlipak MG. Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders. American journal of kidney diseases : the official journal of the National Kidney Foundation 2018. PMID: 29602632


  43. Jotwani V, Atta MG, Estrella MM. Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy. Volume 28 of Issue 11. Journal of the American Society of Nephrology : JASN 2017. PMID: 28784698


  44. Ix JH, Jotwani V, Shlipak MG. In Reply to 'Urinary Excretion of a1-Microglobulin Does Not Predict Graft Loss in Stable Kidney Transplant Recipients'. American journal of kidney diseases : the official journal of the National Kidney Foundation 2017. PMID: 28501241


  45. Park M, Katz R, Shlipak MG, Weiner D, Tracy R, Jotwani V, Hughes-Austin J, Gabbai F, Hsu CY, Pfeffer M, Bansal N, Bostom A, Gutierrez O, Sarnak M, Levey A, Ix JH. Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017. PMID: 28371433


  46. Chen R, Scherzer R, Hsue PY, Jotwani V, Estrella MM, Horberg MA, Grunfeld C, Shlipak MG. Association of Tenofovir Use With Risk of Incident Heart Failure in HIV-Infected Patients. Volume 6 of Issue 4. Journal of the American Heart Association 2017. PMID: 28438737


  47. Baxi SM, Scherzer R, Jotwani V, Estrella MM, Abraham AG, Parikh CR, Bennett MR, Cohen MH, Nowicki MJ, Gustafson DR, Sharma A, Young MA, Shlipak MG. Changes in Urinary Biomarkers Over 10 Years Is Associated With Viral Suppression in a Prospective Cohort of Women Living With HIV. Volume 74 of Issue 5. Journal of acquired immune deficiency syndromes (1999) 2017. PMID: 27759575


  48. Jotwani V, Scherzer R, Estrella MM, Jacobson LP, Witt MD, Palella F, Ho K, Bennett M, Parikh CR, Ix JH, Shlipak M. Association of HIV infection with biomarkers of kidney injury and fibrosis in the Multicenter AIDS Cohort Study. Volume 22 of Issue 5. Antiviral therapy 2017. PMID: 28054933


  49. Ix JH, Katz R, Bansal N, Foster M, Weiner DE, Tracy R, Jotwani V, Hughes-Austin J, McKay D, Gabbai F, Hsu CY, Bostom A, Levey AS, Shlipak MG. Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial. American journal of kidney diseases : the official journal of the National Kidney Foundation 2016. PMID: 28024930


  50. Jotwani V, Scherzer R, Estrella MM, Jacobson LP, Witt MD, Palella F, Macatangay B, Bennett M, Parikh CR, Ix JH, Shlipak M. Brief Report: Cumulative Tenofovir Disoproxil Fumarate Exposure is Associated With Biomarkers of Tubular Injury and Fibrosis in HIV-Infected Men. Volume 73 of Issue 2. Journal of acquired immune deficiency syndromes (1999) 2016. PMID: 27088295


  51. Jotwani V, Scherzer R, Estrella MM, Jacobson LP, Witt MD, Palella FJ, Macatangay B, Bennett M, Parikh CR, Ix JH, Shlipak MG. HIV Infection, Tenofovir, and Urine a1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study. Volume 68 of Issue 4. American journal of kidney diseases : the official journal of the National Kidney Foundation 2016. PMID: 27287300


  52. Scherzer R, Lin H, Abraham A, Thiessen-Philbrook H, Parikh CR, Bennett M, Cohen MH, Nowicki M, Gustafson DR, Sharma A, Young M, Tien P, Jotwani V, Shlipak MG. Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016. PMID: 26754833


  53. Jotwani V, Shlipak MG, Scherzer R, Parekh RS, Kao WH, Bennett M, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Parikh CR, Estrella MM. APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV. Volume 65 of Issue 6. American journal of kidney diseases : the official journal of the National Kidney Foundation 2015. PMID: 25921719


  54. Jotwani V, Scherzer R, Abraham A, Estrella MM, Bennett M, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Ix JH, Sarnak MJ, Parikh CR, Shlipak MG. Association of urine a1-microglobulin with kidney function decline and mortality in HIV-infected women. Volume 10 of Issue 1. Clinical journal of the American Society of Nephrology : CJASN 2014. PMID: 25370597


  55. Jotwani V, Scherzer R, Abraham A, Estrella MM, Bennett M, Devarajan P, Anastos K, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Grunfeld C, Parikh CR, Shlipak MG. Does HIV infection promote early kidney injury in women? Volume 19 of Issue 1. Antiviral therapy 2013. PMID: 23970313


  56. Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG. Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. Volume 59 of Issue 5. American journal of kidney diseases : the official journal of the National Kidney Foundation 2011. PMID: 22206742


  57. Jotwani V, Scherzer R, Choi A, Szczech L, Polak JF, Kronmal RA, Grunfeld C, Shlipak M. Reduced kidney function and preclinical atherosclerosis in HIV-infected individuals: the study of fat redistribution and metabolic change in HIV infection (FRAM). Volume 33 of Issue 5. American journal of nephrology 2011. PMID: 21508633


  58. Kolavennu V, Zeng L, Peng H, Wang Y, Danesh FR. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes 2007. PMID: 18083785